Drug Profile
Research programme: fullerene-based nanomedicines - Luna Innovations
Alternative Names: Buckminsterfullerenes; BuckyballsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Luna Innovations
- Class Fullerenes
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypersensitivity; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Allergy in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in USA
- 23 Jul 2008 Preclinical trials in Allergy in USA (unspecified route)